# Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy

> **NCT00160186** · PHASE4 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 40 (—)

## Conditions studied

- Gastrectomy

## Interventions

- **DRUG:** Pancreatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00160186
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160186, "Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00160186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*